Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SYRS | Syros Pharmaceuticals, Inc. | Director | $367K | Oct 31, 2024 | ||
SGEN | Seagen Inc. | Director | Dec 14, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|